Skip to main content

Day: April 3, 2020

Man Group PLC : Form 8.3 – Pollen Street Secured Lending PLC – Amendment

Amendment to cash-settled derivatives transactions, section 3(b).FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options),...

Continue reading

TCR² Therapeutics to Present at the Goldman Sachs Cell Therapy Day

CAMBRIDGE, Mass., April 03, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced that Alfonso Quintás Cardama, M.D., Chief Medical Officer of TCR2 Therapeutics, will present an update on company progress during the panel “Emergence of TCRs and Next-Generation Therapies” at the Goldman Sachs Cell Therapy Day on April 6, 2020 at 2:00pm ET using a virtual platform.About TCR2 TherapeuticsTCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer. TCR2’s proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells) specifically recognize and kill cancer cells by harnessing...

Continue reading

OCWEN FINANCIAL PROVIDES COMPANY UPDATE

Taking Decisive Action to Address COVID-19Updating 2020 Earnings Guidance due to Evolving Business and Financial Implications of COVID-19WEST PALM BEACH, Fla., April 03, 2020 (GLOBE NEWSWIRE) — Ocwen Financial Corporation (NYSE: OCN) (“Ocwen” or the “Company”), a leading non-bank mortgage servicer and originator, today provided an update on its actions to address the COVID-19 pandemic, as well as its liquidity, mortgage originations, mortgage servicing rights (“MSR”) valuations and 2020 earnings guidance in the context of the COVID-19 pandemic.Glen A. Messina, President and CEO of Ocwen, said, “As the COVID-19 pandemic continues to impact our communities, our first priority is safeguarding and supporting our employees and maintaining business continuity so that we can continue providing service and support to our clients and customers....

Continue reading

Photocat has agreed to complete a private placement of SEK 3.5 million to institutional investors to support growth and ad economic security in times of Covid-19

2nd April 2020Photocat has agreed to complete a private placement of SEK 3.5 million to institutional investors to support growth and ad economic security in times of Covid-19Photocat A/S (publ) today announces that it will complete a private placement of 250,000 new shares to its institutional investors, providing Photocat A/S with around SEK 3.5 million in new equity. Photocat has sufficient working capital prior to the placement.The Board of Directors in Photocat A/S has utilized authorization in the Company’s articles of association to complete a private placement without preferential rights for the current shareholders. The issue of 250,000 new shares has been completed at a price of SEK 14.0 pr. share with a nominal amount of DKK 1 each. The price per share is public listed share price as per closing 2nd April 2020 on First North,...

Continue reading

Investeringsselskabet Artha Optimum A/S – indkaldelse til generalforsamling

Selskabsmeddelelse nr. 11, 2020Holte, 3. april 2020Indkaldelse til ordinær generalforsamling iInvesteringsselskabet Artha Optimum A/SMed ønske om at begrænse smitterisikoen og henset til de særlige forhold, der gør sig gældende som følge af COVID-19, henstiller bestyrelsen til at afgive fuldmagt eller benytte sig af brevstemme.Investeringsselskabet Artha Optimum A/S afholder ordinær generalforsamling tirsdag den 28. april 2020 kl. 10:15 på selskabets adresse, Søllerødvej 64, 2840 HolteDagsorden:Bestyrelsens beretning om selskabets virksomhed i det forløbne år.Fremlæggelse af årsrapport til godkendelse.Beslutning om anvendelse af årets resultat.Valg af medlemmer til bestyrelsen.Valg af revisor.Eventuelt.Der henvises i øvrigt til vedhæftede indkaldelse med den fuldstændige dagsorden.Spørgsmål vedrørende denne meddelelse kan rettes til:Kristian...

Continue reading

CytoDyn Files Request with FDA for Preliminary Meeting for Breakthrough Therapy Designation for Leronlimab in the Treatment of Cancer

VANCOUVER, Washington, April 03, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that it has filed a request with the U.S. Food and Drug Administration (FDA) for a preliminary meeting to discuss new clinical data which the Company believes further supports its objective to obtain Breakthrough Therapy designation (BTD) for leronlimab in the treatment of metastatic triple-negative breast cancer (mTNBC). The FDA had previously granted Fast Track designation to leronlimab for the treatment of mTNBC. Last month, the Company reported that the FDA had recommended such a meeting to provide preliminary advice prior to resubmission of a Breakthrough...

Continue reading

Government guarantee programme for companies now accepting applications

To mitigate the economic impact of the coronavirus pandemic, the Government has set up a programme for emergency economic relief that involves state guarantees for loans to companies affected by the virus outbreak. Banks now have the opportunity to participate in the guarantee programme.The government guarantee programme for companies entails that the central government takes on most of the risk when banks and credit institutions lend to companies that are financially impacted by the coronavirus but are otherwise viable. The participation of banks and other credit institutions in the programme and, to a greater extent, their granting of loans to viable companies is crucial in order for the aid to have an effect and help more businesses manage the crisis.Starting today, banks and other credit institutions can apply to be able to utilise...

Continue reading

Företagsakuten öppnar för ansökningar

För att mildra de ekonomiska konsekvenserna av coronapandemin har regeringen inrättat en Företagsakut, som innebär statliga garantier för lån till företag som drabbats av virusutbrottet. Nu öppnar möjligheten för banker att ansluta sig till garantiprogrammet.Företagsakuten innebär att staten tar huvuddelen av risken vid utlåning till företag som drabbas ekonomiskt av coronaviruset men som för övrigt är livskraftiga. Att banker och andra kreditinstitut deltar i programmet och i vidare utsträckning beviljar lån till livskraftiga företag är nödvändigt för att stödet ska få effekt och bidra till att fler företag klarar krisen.Från och med i dag är det möjligt för banker och andra kreditinstitut att ansöka om att få ta del av de statliga lånegarantierna.– Företagsakuten kommer att vara en viktig pusselbit för att fler företag ska klara sig...

Continue reading

Himax Technologies, Inc. Pre-announces Preliminary Unaudited First Quarter 2020 Financial Results

TAINAN, Taiwan, April 03, 2020 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today pre-announced preliminary unaudited key financial results for the three months ended March 31st, 2020. The first quarter revenues met its guidance, while gross margin and EPS both exceeded guidance issued on February 13th, 2020. Revenues were $184.6 million, an increase of 5.5% sequentially versus the guidance of an increase between 1.0% to 10.0%. This represents an increase of 13.0% year-over-year.Gross Margin was around 22.7%, exceeding the guidance of an increase of 1.0% to 2.0% from the 20.6% delivered in the fourth quarter of 2019.IFRS earnings per diluted ADS were expected to be around 1.9 cents, exceeding the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.